ArticleBMC gastroenterology2026
Differential diagnosis of solitary rectal ulcer syndrome and early rectal cancer via endorectal ultrasound: a retrospective matched case-control study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSolitary rectal ulcer syndrome (SRUS) is a rare chronic rectal disease with nonspecific symptoms and endoscopic findings that overlap with rectal cancer, leading to misdiagnosis in up to 64%. Biopsy is often limited by insufficient depth. Data on the use of endorectal ultrasound (ERUS) for differentiating SRUS from early rectal cancer (ERC) are scarce. Thus, this study aims to identify ERUS features that differentiate SRUS from ERC (T1 and T2 stages).
methodsTwenty-nine patients who were pathologically diagnosed with SRUS between 2015 and 2024 were enrolled, whereas ERC patients were randomly selected at a 1:1 ratio and matched based on sex and lesion-to-anal verge distance. The ERUS features and clinical information of the two groups were compared via t tests, Wilcoxon rank sum tests or chi-square tests. Predictive factors for SRUS were analyzed via univariable and multivariable logistic regression. Diagnostic performance was assessed using ROC curves.
resultsSRUS patients were younger and presented with constipation more frequently than ERC patients did (P < 0.001 and P = 0.013, respectively). Compared with ERC lesions, SRUS lesions were more frequently located in the anterior rectal wall (44.83% vs. 13.79%, P = 0.044), were longer (median: 37 mm vs. 26 mm, P = 0.002), and had greater rectal circumferential involvement (41.38% vs. 13.79%, P = 0.019). Similarly, rectal wall thickening with preserved layer stratification and anarchic vascularization were more frequently observed in the SRUS group (79.31% vs. 13.79% and 96.55% vs. 65.52%, respectively; both P < 0.05). Multivariable logistic regression revealed that age (OR:0.87; 95% CI:0.78-0.97; P = 0.014), rectal wall thickening with preserved layer stratification (OR: <0.001, 95% CI: 0.00-0.36, P = 0.015) and > 50% circumferential involvement (OR: 97.04, 95% CI: 1.32-7,134.40, P = 0.037) were independent factors for differentiating between SRUS and ERC. The area under the curve (AUC) was 0.815, 0.638, 0.828, and 0.933 for age, circumferential involvement, layer stratification, and their combination, respectively, in the diagnosis of SRUS.
conclusionERUS features, including anterior wall location, longer lesions, > 50% circumferential involvement, rectal wall thickening with preserved layer stratification, and anarchic vascularization, are typical ERUS findings of SRUS. Younger patient age, preserved layer stratification and > 50% circumferential involvement are particularly valuable for differential diagnosis between SRUS and ERC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.